Search - tctmd.com

Displaying 881 - 900 of 972

Sort: Relevancy | Date

News Industry News

STENTYS concludes clinical trial ahead of plan

January 31, 2012

News Conference News Cell Therapy 2012

Expedited Cell Therapy After STEMI Shows Promise

January 29, 2012

News Industry News

Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial

January 15, 2012

News Daily News

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

L.A. McKeown

January 09, 2012

News Daily News

Study Shines Spotlight on US Readmissions After STEMI

Yael L. Maxwell

January 04, 2012

News Daily News

Clopidogrel Prescriptions Not Being Filled Fast Enough, If at All

Yael L. Maxwell

December 14, 2011

News Daily News

Most Cath Lab Activations by Emergency Personnel for Suspected STEMI Appropriate

December 11, 2011

News Daily News

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

L.A. McKeown

December 08, 2011

News Daily News

Hospital Readmission Post-PCI Linked to Increased Mortality

Yael L. Maxwell

December 05, 2011

News Industry News

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

November 21, 2011

News Conference News

No LateTIME Benefit for Cell Therapy After Primary PCI

November 14, 2011

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

News Industry News

Paclitaxel-coated balloon angioplasty demonstrates superior results

November 10, 2011

News Industry News

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

November 10, 2011

News Industry News

Clinical trial of a new dual therapy stent establishes non-inferiority compared to paclitaxel-eluting stent

November 10, 2011

News Industry News

Use of drug-eluting balloons with bare metal stents do not show superiority over drug-eluting stents

November 09, 2011

News Industry News

OrbusNeich Introduces the Combo™ Dual Therapy Stent at TCT 2011

November 09, 2011

News Industry News

Clinical trial supports radial artery access as preferable to femoral artery for angioplasty

November 09, 2011

News Industry News

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

November 08, 2011

News Industry News

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

November 08, 2011

Advertisement

STENTYS concludes clinical trial ahead of plan

Expedited Cell Therapy After STEMI Shows Promise

Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

Study Shines Spotlight on US Readmissions After STEMI

Clopidogrel Prescriptions Not Being Filled Fast Enough, If at All

Most Cath Lab Activations by Emergency Personnel for Suspected STEMI Appropriate

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

Hospital Readmission Post-PCI Linked to Increased Mortality

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

No LateTIME Benefit for Cell Therapy After Primary PCI

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

Paclitaxel-coated balloon angioplasty demonstrates superior results

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

Clinical trial of a new dual therapy stent establishes non-inferiority compared to paclitaxel-eluting stent

Use of drug-eluting balloons with bare metal stents do not show superiority over drug-eluting stents

OrbusNeich Introduces the Combo™ Dual Therapy Stent at TCT 2011

Clinical trial supports radial artery access as preferable to femoral artery for angioplasty

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content